CytomX Therapeutics
CTMX
CTMX
122 hedge funds and large institutions have $359M invested in CytomX Therapeutics in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 56 increasing their positions, 35 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
62% less call options, than puts
Call options by funds: $132K | Put options by funds: $351K
Holders
122
Holding in Top 10
–
Calls
$132K
Puts
$351K
Top Buyers
| 1 | +$14.7M | |
| 2 | +$9.58M | |
| 3 | +$7.96M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.33M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$5.17M |
Top Sellers
| 1 | -$43.1M | |
| 2 | -$6.38M | |
| 3 | -$3.25M | |
| 4 |
Renaissance Technologies
New York
|
-$2.7M |
| 5 |
Two Sigma Investments
New York
|
-$2.53M |